Overview: A New Frontier in Asthma Treatment Researchers are heralding a potential turning point for asthma management with depemokimab, a biologic therapy that may reduce the need for frequent injections. Unlike traditional daily or monthly biologics, this emerging approach could halve the number of injections required, delivering a dose twice per year. The development has…